Medicine
Nabi-HB 1560 IU/5 mL injection
Nabi-HB 1560 IU/5 mL injection is a prescription medicine containing Human hepatitis b virus immune globulin for intramuscular use, marketed by ADMA Biologics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Refrigerate between 2 to 8 °C (36 to 46 °F). Do not freeze.
Key facts
- Active ingredient (INN)
- Human hepatitis b virus immune globulin
- Brand
- Nabi-HB
- Strength
- 1560 IU/5 mL
- Dosage form
- Injection
- Route
- Intramuscular
- Packs
- 1 vial
- Marketing authorisation holder
- ADMA Biologics
- Manufacturer
- ADMA Biologics
- Origin register
- US FDA, United States
- Storage
- Refrigerate between 2 to 8 °C (36 to 46 °F). Do not freeze.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J06BB04 Human hepatitis b immunoglobulin
- HS code (indicative)
- 3002.12Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 October 2001
- Identifiers
- RxCUI 1658125, 1658127DailyMed set ID 47fe1a99-5078-4b89-84fa-9e8387baec5cNDC 69800-4203Application BLA103945
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-use in 1 carton / 5 mL in 1 vial, single-use | 69800-4203-1 | ADMA Biologics | 23 October 2001 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Human hepatitis b virus immune globulin
Clinical summary
Human hepatitis b virus immune globulin is a human immunoglobulin indicated for treatment of acute exposure to blood containing HBsAg, perinatal exposure of infants born to HBsAg-positive mothers, among other approved uses. MedsAcross supplies Human hepatitis b virus immune globulin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Human hepatitis b virus immune globulinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Nabi-HB prescribing information (ADMA Biologics) · U.S. National Library of Medicine, DailyMed
Need Nabi-HB 1560 IU/5 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.